Trials / Unknown
UnknownNCT02801565
Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS
Clinical Observation of Recombinant Human Growth Hormone Injection Assisted in Vitro Fertilization and Embryo Transfer (IVF-ET) in the Treatment of Polycystic Ovary Syndrome (PCOS)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 208 (estimated)
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 25 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Observe validity of Recombinant Human Growth Hormone Injection assisted in IVF-ET (in vitro fertilization and embryo transfer) treatment of PCOS (polycystic ovary syndrome) patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Conventional controlled ovarian stimulation proctol | Conventional controlled ovarian stimulation proctol without rhGH. |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-02-01
- First posted
- 2016-06-16
- Last updated
- 2016-11-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02801565. Inclusion in this directory is not an endorsement.